YB
Therapeutic Areas
Everads Therapy Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VV-14295 | Geographic atrophy (dry AMD) | Phase 1 |
Leadership Team at Everads Therapy
MW
Moshe Weinstein
Executive Chair & CEO
HD
Hagay Drori
CTO
KM
Keren Mano Tamir, MD
Head of Scientific Strategy, Communications and Business Development
YC
Yonatan Cohavi
CFO
AI
Alla Iserlis
Head of QA
MM
Miriam Mangelus, PhD, MBA
Head of R&D Search and Evaluation
AB
Adi Bigger Hoggeg
Head of Clinical Operations